Assessment of the benefit of achieving complete versus almost complete skin clearance in psoriasis: a patient’s perspective-Reference-Cited by-同舟云学术

Assessment of the benefit of achieving complete versus almost complete skin clearance in psoriasis: a patient’s perspective

Published:2020-06-01 Issue: Volume: Page:1-7
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Korman Neil J.¹,Malatestinic William²,Goldblum Orin M.²,Murage Mwangi J.²^ORCID,Renda Lisa²,Lin Chen-Yen²,Lucas James³^ORCID,Middleton Chloe³,Lobosco Steven³

Affiliation:

1. University Hospitals Case Medical Center, Cleveland, OH, USA;

2. Lilly USA, LLC, Indianapolis, IN, USA;

3. Adelphi Real World, Bollington, UK

Publisher

Informa UK Limited

Subject

Dermatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2020.1772454

Reference42 articles.

1. Psoriasis causes as much disability as other major medical diseases

2. Quality of life issues in psoriasis

3. Quality-of-life issues in psoriasis

4. The association of socioeconomic and clinical characteristics with health-related quality of life in patients with psoriasis: a cross-sectional study

5. Relationship between psoriasis severity, clinical symptoms, quality of life and work productivity among patients in the USA

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patients with Persistent Mild Psoriasis after Treatment with Ustekinumab Achieved Greater Improvements in Skin Clearance and Patient-reported Outcomes after Switching to Guselkumab in the Phase 3 NAVIGATE Trial;Acta Dermato-Venereologica;2024-09-05

2. Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study – IL PSO (Italian Landscape Psoriasis);Journal of Dermatological Treatment;2024-08-20

3. Long-Term Safety of Risankizumab in Patients with Psoriatic Disease: A Comprehensive Analysis from Clinical Trials;Dermatology and Therapy;2024-08-17

4. Secukinumab and Dead Sea Climatotherapy Impact Resolved Psoriasis Skin Differently Potentially Affecting Disease Memory;International Journal of Molecular Sciences;2024-05-31

5. Real-World Long-Term Effectiveness of Risankizumab Among Patients with Moderate-to-Severe Psoriasis: Analysis from an International Medical Chart Review (RAPID) Study;Dermatology and Therapy;2024-05